• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

NYU-Led Study Finds Removal of Gene Prevents Development of Aggressive Pancreatic Cancer in Mice

Article

A study led by researchers from the NYU School of Medicine and the University of Michigan has found that the action of a gene called ATDC is required for the development of pancreatic cancer.

A study led by researchers from the NYU School of Medicine and the University of Michigan has found that the action of a gene called ATDC is required for the development of pancreatic cancer. These findings were demonstrated in a study of mice and human patient samples.

The research builds upon the theory that many cancer arise when adults cells switch back into more “primitive,” high-growth cell types, like those that drive fetal development. When this reversion happens in the presence of other genetic mistakes, a repair process meant to start and stop quickly remains unchecked.

Read the full release.

Related Videos
Screenshot of Fran Gregory, PharmD, MBA, during a video interview
Yael Mauer, MD, MPH
Pregnant Patient | image credit: pressmaster - stock.adobe.com
Dr Julie Patterson, National Pharmaceutical Council
Diana Isaacs, PharmD
Beau Raymond, MD
Robert Zimmerman, MD
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
Beau Raymond, MD
Judith Alberto, MHA, RPh, BCOP, director of clinical initiatives, Community Oncology Alliance
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.